Study of MK-3475 Alone or in Combination With Copanlisib in Relapsed or Refractory NK and T-cell Non-Hodgkin Lymphoma
Clinical trial NCT02535247 · TERMINATED
Trial details
- NCT number
- NCT02535247
- Sponsor
- Fox Chase Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-05
- Primary completion
- 2020-02-25
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.